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Abstract
Background: Vitamin D status, as indicated by 25-hydroxyvitamin D is inversely associated with adiposity, glucose
homeostasis, lipid profiles, and blood pressure along with its classic role in calcium homeostasis and bone
metabolism. It is also shown to be inversely associated with metabolic syndrome and cardiovascular diseases in
western populations. However, evidence from the Asian population is limited. Therefore, we aim to study the
prevalence of vitamin D insufficiency (< 50 nmol/L) and the association of 25-hydroxyvitamin D with metabolic risk
factors among an existing Malay cohort in Kuala Lumpur.
Methods: This is an analytical cross sectional study. A total of 380 subjects were sampled and their vitamins D
status (25-hydroxyvitamin D), fasting blood glucose, full lipid profile were assessed using venous blood. Systolic and
diastolic blood pressure, weight, height and waist circumference were measured following standard protocols.
Socio-demographic data such as sex, age, smoking status etc were also collected. Data was analysed using t-test,
chi-square test, General Linear Model and multiple logistic regression.
Results: Females made up 58% of the sample. The mean age of respondents was 48.5 (SD 5.2) years. Females had
significantly lower mean Vitamin D levels (36.2; 95% CI: 34.5, 38.0 nmol/L) compared to males (56.2; 95% CI: 53.2,
59.2 nmol/L). Approximately 41% and 87% of males and females respectively had insufficient (< 50 nmol/L) levels
of 25-hydroxyvitamin D (p < 0.001). The prevalence of Metabolic Syndrome for the whole sample was 38.4 (95% CI:
33.5, 43.3)%. In the multivariate model (adjusted for age, sex, abdominal obesity, HDL-cholesterol, diastolic blood
pressure), insufficient Vitamin D status was significantly associated with 1-year age increments (OR: 0.93; 95% CI:
0.88, 0.98), being female (OR: 8.68; 95% CI: 5.08, 14.83) and abdominal obesity (OR: 2.57; 95% CI: 1.51, 4.39).
Respondents with insufficient vitamin D were found to have higher odds of having Metabolic Syndrome (OR: 1.73;
95% CI: 1.02, 2.92) after adjusting for age and sex.
Conclusions: Our results highlight the high prevalence of vitamin D insufficiency among Malay adults in Kuala
Lumpur. Vitamin D insufficiency is independently associated with younger age, female sex and greater abdominal
obesity. Vitamin D insufficiency is also associated with Metabolic Syndrome.
Background
Clinically, vitamin D has an established role in calcium
and bone metabolism. Recently, vitamin D insufficiency
has been shown to be associated with increased risk of
developing type 2 diabetes mellitus and cardiovascular
disease (CVD), as well as with cardiovascular risk factors
such as hypertension and obesity [1]. Systematic reviews
[2-4] suggest a possible inverse association between
Vitamin D and cardiovascular risks. In a meta-analysis
by Parkera et al [5], individuals with the highest levels
of serum vitamin D were associated with a 43% reduc-
tion in cardio-metabolic disorders (OR 0.57, 95% CI:
0.48-0.68).
Vitamin D is synthesized in the skin after sunlight
exposure or can be obtained through a balanced dietary
intake. However, it is well known that natural sources of
vitamin D in foods are not sufficient to supply the nor-
mal body requirements. Therefore, skin synthesis of
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constitute the major source of vitamin D [6]. This sig-
nificant role of sunlight in vitamin D synthesis suggests
a low prevalence of vitamin D deficiency in tropical
countries. However, studies carried out in Hawaii, Tur-
key, India, Iran and Saudi Arabia had shown a high pre-
valence of vitamin D deficiency [7-11] with the
respondents’ behavior of avoiding sunlight or clothing
which prevented sunlight exposure being the reasons for
this phenomenon.
Malaysia is a tropical country located at the Equator
and is sunny all year round. However, the information
on vitamin D status of the adult population is scarce.
To date, the only available Malaysian studies were
focused on the association of vitamin D status and bone
health among child-bearing [12] and post-menopausal
women [13]. These studies did not particularly focus on
vitamin D and cardiometabolic risks. Recent evidence
show possible associations of vitamin D status with
metabolic syndrome, diabetes, cardiovascular diseases
and cancers in the long term [1-3,14,15]. This may
increase the incidence of metabolic syndrome and these
chronic diseases in the future. In this study, we set out
to look at the vitamin D status of a Malay cohort in
Kuala Lumpur; and to demonstrate the association of
metabolic risk factors with vitamin D status.
Methods
Study design & sampling method
This was an analytical cross-sectional study which was
part of a voluntary health screening program in a public
university in Kuala Lumpur. Universal sampling was
conducted where all employees aged 35 years and above
were invited to participate. From this population, a con-
venient sample of 380 Malay employees agreed to parti-
cipate in our study to assess their vitamin D status. The
sample size of 380 was constrained by our limited
research budget.
Study population
The majority (70%) of employees in this public univer-
sity are of Malay ethnicity. They are Muslims by reli-
gion; tend to have darker skin and most of the females
adopt concealing dressing style such as veils (head
scarves, face not covered), long sleeves, long skirts etc.
Most of the employees in this university work indoors.
Ethics consideration
Approval was obtained (Reference Number: MEC
782.18) from the Medical Ethics Committee of the
Medical Faculty which is responsible for ethical issues
in all research projects involving humans conducted
by Medical Faculty staff of the university. Approval
was also obtained from the management of the
university. Written informed consent was given by all
participants.
Data Collection
Data was collected during the health screening from
May to July 2010 in the university campus. Vitamin D
status of the participants was assessed using venous
blood. Vitamin D adequacy was evaluated by measuring
serum 25-hydroxyvitamin D (25 (OH) D) concentration,
as this was the primary circulating form of vitamin D.
This serum concentration of 25(OH)D is a good reflec-
tion of cumulative exposure to sunlight and dietary
intake of vitamin D, and is widely regarded as a robust
‘’gold standard” indicator of vitamin D status [16]. The
biochemical test used was the LAISON(R) 25 OH Vita-
min D TOTAL Assay. This assay used chemilumines-
cent immunoassay (CLIA) technology for the
quantitative determination of 25(OH)D. These biochem-
ical analyses were outsourced to a private laboratory
with international quality control Certificate of Accredi-
tation (MS ISO 15189).
There are a few categories of Vitamin D status accord-
ing to circulating 25 OH Vitamin D [17]. The categories
are (i) deficiency (< 25 nmol/l) where clinical alterations
such as rickets, osteomalacia, myopathy, calcium malab-
sorption, severe hyperparathyroidism, impaired immune
and cardiac function happen; (ii) insufficiency (25 - 49.9
nmol/l) where reduced bone mineral density, impaired
muscle function, low intestinal calcium absorption rates,
elevated PTH levels occur; (iii) hypovitaminosis (50 to
99.9 nmol/l) where slightly elevated PTH levels occur;
(iv) adequacy (100 nmol/l) with no disturbances of vita-
min D dependent functions and (v) intoxication when
the level of 25 OH Vitamin D exceeds 250 nmol/l. In
our study, subjects with 25 OH Vitamin D levels less
than 50 nmol/L or 20 ng/ml were classified as having
insufficient Vitamin D [17]. (To convert 1 nmol/L to 1
ng/ml is to divide by 2.5.)
Resting blood pressure was measured using a clinically
validated digital automatic blood pressure monitor
(Omron HEM - 907 model) while fasting lipid profile
was analyzed using the Dimension
® clinical chemistry
system which was an in-vitro diagnostic test. All bio-
chemical analysis was conducted by the Clinical Diag-
nostic Laboratory of the medical centre from the same
university.
Anthropometric measurements such as weight, height
and waist circumference were also taken. Weight and
height were measured using calibrated digital weighing
scales and stadiometers respectively. The waist and hip
circumferences were measured with a circumference mea-
surement tape. The waist was defined as the point midway
between the iliac crest and the costal margin (lower rib);
while the hip circumference was defined as being the
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crest [18,19]. All measurements were conducted by trained
staff and quality checks were conducted regularly.
Body Mass Index (BMI) was derived following the for-
mula of weight in kg/height
2 in meters. Overweight was
defined using the Asian BMI range of 23.0 to 26.9 kgm
2
while obesity was defined as having a BMI ≥ 27 kgm
2 [20].
Metabolic Syndrome was defined according to the modi-
fied NCEP criteria [21], where the presence of any three of
the following five factors is required for a diagnosis of
Metabolic Syndrome: abdominal obesity (waist circumfer-
ence > 90 cm in men and > 80 cm in women), hypertrigly-
ceridaemia (triglycerides ≥ 1.7 mmol/L); low HDL
cholesterol (HDL cholesterol ≤ 1.03 mmol/L for men and
≤ 1.29 mmol/L for women); elevated blood pressure (sys-
tolic blood pressure ≥ 130 mmHg and/or diastolic blood
pressure ≥ 85 mmHg or current use of antihypertensive
drugs); impaired fasting glucose (fasting plasma glucose ≥
5.6 mmol/L). A short questionnaire enquiring socio-demo-
graphic characteristics, medical history of diabetes mellitus
and hypertension (self-reported as diagnosed by medical
doctors) was self-administered.
Data Analysis
Data was entered and analysed using SPSS for Windows
version 16.0. Categorical variables were presented as
frequencies and percentages while quantitative variables
were presented as mean ± standard deviation (sd) or
95% confidence interval (CI) where appropriate. Inde-
pendent t test and Chi square test were used in univari-
ate analysis. The General Linear Model (GLM) was used
to adjust for gender differences on quantitative variables.
Multiple logistic regression was conducted by including
risk factors with p < 0.2 into the model to predict the
risk factors significantly associated with vitamin D insuf-
ficiency. If both BMI and waist circumference were
found to be significant, the one with the smaller p value
will be selected as both are indicators of obesity and will
produce collinearity if both are included in the model.
Results
A total of 380 Malay employees participated in this
study with 58.4% being females. Their mean age was
48.5 ± 5.2 years with males being significantly older
(Table 1). Ninety five participants were hypertensive. Of
these, 90.5% of them were currently on treatment, while
forty one of them were diabetics with 82.9% on treat-
ment. There was no significant difference (p > 0.05) in
the systolic (147.4 ± 20.5 mm Hg vs 147.7 ± 13.3 mm
Hg respectively) and diastolic blood pressures (89.6 ±
11.8 mm Hg vs 88.4 ± 5.5 mm Hg respectively) among
the treated and untreated hypertensive participants.
Table 1 Baseline characteristics of participants by gender
Characteristics Total (n = 380) n (%) Male (n = 158) n (%) Female (n = 222) n (%) p value
Diabetes mellitus 41 (10.8) 19 (12.0) 22 (9.9) 0.51§
Hypertension 95 (25.0) 45 (28.5) 50 (22.5) 0.19§
Current smoker 37 (9.7) 37 (100) 0 (0) < 0.001§
BMI status: Normal weight 60 (15.8) 29 (18.4) 31 (14.0) 0.12§
Overweight 127 (33.4) 59 (37.3) 68 (30.6)
Obese 193 (50.8) 70 (44.3) 123 (55.4)
25 OH Vit D Insufficiency (< 50 nmol/l) 258 (67.9) 65 (41.1) 193 (86.9) < 0.001§
Metabolic syndrome 146 (38.4) 64 (40.5) 76 (34.2) 0.21§
(mean ± s.d.) (mean ± s.d.) (mean ± s.d.)
Age (years) 48.5 ± 5.2 49.6 ± 5.7 47.7 ± 4.6 < 0.001‡
BMI (kg/m
2) 27.5 ± 4.6 26.7 ± 4.3 28.1 ± 4.8 0.04‡
Waist circumference (cm) 87.5 ± 10.4 90.9 ± 9.9 85.0 ± 9.9 < 0.001‡
Systolic blood pressure (mm Hg) 133.7 ± 18.7 136.2 ± 15.8 132.0 ± 20.4 0.03‡
Diastolic blood pressure (mm Hg) 82.1 ± 11.5 83.4 ± 10.5 81.1 ± 12.1 0.06‡
Fasting blood glucose (mmol/l) 5.9 ± 2.4 5.9 ± 2.1 5.9 ± 2.6 0.95‡
Triglycerides (mmol/l) 1.6 ± 0.9 1.9 ± 0.9 1.4 ± 0.7 < 0.001‡
Total cholesterol (mmol/l) 5.4 ± 0.9 5.5 ± 0.9 5.4 ± 0.9 0.44‡
HDL-cholesterol (mmol/l) 1.3 ± 0.3 1.2 ± 0.2 1.4 ± 0.3 < 0.001‡
LDL-cholesterol (mmol/l) 3.3 ± 0.9 3.4 ± 0.8 3.3 ± 0.8 0.24‡
25 OH Vitamin D (nmol/l) 44.5 ± 18.7 56.2 ± 19.0 36.2 ± 13.4 < 0.001‡
‡t test, §chi-square test
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fasting blood glucose of treated (10.2 ± 3.9 mmol/l) and
untreated (9.9 ± 4.0 mmol/l) diabetic participants.
About 10% of them were current smokers who were all
males. Only one third of the participants had sufficient
levels of vitamin D (≥ 50 nmol/L). More than 80% of
participants were overweight or obese. Approximately
40% of the participants were diagnosed with Metabolic
Syndrome. There were no gender difference observed in
hypertension, diabetes mellitus, BMI status and meta-
bolic syndrome except for current smokers (100%
males) and insufficiency of vitamin D where there were
more females (87%) had insufficient levels of 25 OH
Vitamin D compared to males (41%)(p < 0.001).
The metabolic risk factors are also presented in Table
1. Males were found to have significantly higher read-
ings in waist circumference, systolic and diastolic blood
pressure, triglycerides and 25 OH Vitamin D levels com-
pared to their counterpart (p < 0.05). On the other
hand, females had significantly higher mean BMI and
HDL-cholesterol levels than males (p < 0.05). There was
no difference in fasting blood glucose, total cholesterol
and LDL-cholesterol levels between the sexes (p > 0.05).
Table 2 displays the comparison between the sufficient
and insufficient vitamin D groups adjusted by gender.
The vitamin D insufficient group was significantly
younger (p < 0.001). Obesity as reflected by BMI and
waist circumference was strongly associated with Vita-
min D status (p < 0.001). The mean BMI and waist cir-
cumference was significantly (p < 0.001) higher in the
vitamin D insufficient group. There was no significant
association between vitamin D insufficiency with systolic
and diastolic blood pressure, HDL-cholesterol and glu-
cose except for triglycerides, which was significantly
higher in the vitamin D insufficient group (p = 0.018).
However, significant association was found between vita-
min D levels and total metabolic risk scores. Those with
vitamin D insufficiency had higher metabolic risk scores
(p = 0.009).
Table 3 shows the crude and adjusted Odds Ratio
(OR) of metabolic risk factors with vitamin D status. In
the crude analysis; age, female, BMI, waist circumfer-
ence and HDL-cholesterol were found to be significantly
associated with vitamin D insufficiency (< 50 nmol/l). In
the multivariate model (adjusted by age, sex, waist cir-
cumference, diastolic blood pressure and low HDL-cho-
lesterol); only age, sex and waist circumference
remained significant (p < 0.05). Older age participants
were found to have lower odds of having vitamin D
insufficiency, while females had 8.68 (95% CI: 5.08,
14.83) times odds of having vitamin D insufficiency. Par-
ticipants who were obese (indicated by central obesity)
too had significantly higher odds (2.57; 95% CI: 1.51,
4.39) of having vitamin D insufficiency. Other metabolic
risk factors were not statistically associated with vitamin
D status. In a separate model adjusted by age and sex,
participants with vitamin D insufficiency had signifi-
cantly higher odds of having metabolic syndrome (1.73;
95% CI: 1.02, 2.92).
Discussion
The serum 25-hydroxyvitamin D, 25(OH)D level for
optimal health appears to be in the range of 100-150
nmol/L [5,22]. Our findings demonstrated a high pro-
portion (approximately 70%) of participants with insuffi-
cient vitamin D level (< 50 nmol/L or 20 ng/ml). In
many countries throughout all continents, vitamin D
insufficiency (< 50 nmol/L) exists in around 50% of the
populations [23]. Within the Asian region, there are not
many reports on vitamin D status of the population
except pockets of studies among children, pregnant
women or post-menopausal women. In India, generally
low serum 25(OH)D concentrations have been reported.
The mean serum 25(OH)D was 30 nmol/L in a survey
Table 2 Comparison of metabolic risk factors according to Vitamin D status
Vitamin D Insufficiency
Metabolic risk factors Yes
(< 50 nmol/L)
n = 258
mean ± s.d.
No
(≥ 50 nmol/L)
n = 122
mean ± s.d.
GLM p-value
Age (years) 47.77 ± 4.68 49.95 ± 5.82 0.007
BMI (kg/m
2) 28.25 ± 4.64 25.96 ± 4.27 < 0.001
Waist circumference (cm) 87.78 ± 10.34 86.80 ± 10.44 < 0.001
Systolic blood pressure (mm Hg) 133.16 ± 19.04 134.98 ± 18.12 0.915
Diastolic blood pressure (mm Hg) 81.98 ± 11.74 82.24 ± 11.08 0.518
Glucose (mmol/l) 5.99 ± 2.70 5.69 ± 1.67 0.303
Triglyceride (mmol/l) 1.59 ± 0.86 1.64 ± 0.87 0.018
HDL-cholesterol (mmol/l) 1.38 ± 0.31 1.27 ± 0.26 0.714
Total metabolic risk score 2.2 ± 1.4 1.9 ± 1.3 0.009
s.d. - standard deviation
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serum 25(OH)D was 35 nmol/L among pregnant
women [25] and 36 nmol/L in postmenopausal women
[26]. In Beijing, China, mean serum 25(OH)D in adoles-
cent girls was 30 - 36 nmol/L [27]. In Japan, a low
mean serum 25(OH)D of 34 nmol/L was observed in
women younger than 30 years and 30 nmol/L in immo-
bile older persons [28]. In the Korea National Health
and Nutrition Examination Survey (KNHANES), Vita-
min D insufficiency (< 50 nmol/l) was found in 47.3%
males and 64.5% females [29].
In Malaysia, there are few published reports on vita-
min D status among the adult population. One pub-
lished study reported the vitamin D levels of post-
menopausal women [13] and another studied on women
of child bearing age [12]. The vitamin D status of
women from both these studies was better than our
female participants. The mean vitamin D level of post-
menopausal Malay women in the study by Rahman et al
[13] was 44.4 ± 10.6 nmol/L, which was higher than our
female participants. Green et al [12] reported over 60%
of Malaysian women had vitamin D levels below 50
nmol/L compared to ours of approximately 87%.
Our female participants had significantly lower mean
vitamin D levels than males after adjustment for age,
central obesity, HDL-cholesterol and diastolic blood
pressure. Similar results have been reported elsewhere
[7,8,11,23]. Other possible reasons contributing to this
difference could also be explained by their clothing style
(wearing long sleeves, long skirts and veil) which is cul-
turally or religiously related (results not shown). There
have been no published findings on vitamin D levels
among Malaysian men and not many such studies in
other countries. Our male participants’ vitamin D status
are comparable with the Korean males (43% with Vita-
min D insufficiency) [29], poorer than the Vietnam
males (20% with Vitamin D insufficiency) [30] but much
better than males from Middle Eastern countries like
Iran (69% with vitamin D deficiency) [8].
Existing evidence show that elderly individuals are
more likely to have low vitamin D levels [11,23]. How-
ever, we found age to be negatively associated with vita-
min D status, where older participants had higher
vitamin D levels. The reason for this result remains
unclear. Possibly, the age of our working participants
was not representative of the general population where
there were no elderly participants. However, this finding
c o n c u r sw i t ht h a tf r o mt h en a t i o n a ls t u d yf r o mK o r e a
[29] which found Vitamin D insufficiency most preva-
lent in the younger age groups and least prevalent in
the age group of 50 s and above. Further studies are
needed to investigate this paradoxical finding as it
would appear more logical to have it the other way
around.
Abdominal obesity was significantly associated with vita-
min D status; similar to studies reported elsewhere
[31-34]. This may be due to vitamin D being soluble in fat
which is largely sequestered in adipose tissue and is there-
fore low in serum among obese individuals [33,35]. This
will give rise to reduced bioavailability of vitamin D meta-
bolite which regulates transcription of multiple gene pro-
ducts with antiproliferative, prodifferentiative, and
immunomodulatory effects [1]. Consequently, these obese
individuals will be more susceptible to metabolic syn-
drome [36-38] as well as cardiovascular diseases [1-3,17].
Contrary to existing evidence, our findings did not
show significant associations among individual meta-
bolic risk factors such as fasting blood glucose, triglycer-
ides, HDL cholesterol and blood pressure with Vitamin
D status. Our small sample size may not have adequate
power to detect significant association within individual
risk factors. On the other hand, participants with insuffi-
cient vitamin D status had higher odds for metabolic
syndrome after adjustment for age and sex. As reported
Table 3 Comparison of crude and adjusted risks of age, gender and metabolic factors with Vitamin D Insufficiency
Vitamin D Insufficiency
Crude OR (95% CI) P Adjusted OR (95% CI) P
Age 0.92 (0.88, 0.96) < 0.001 0.93 (0.88, 0.98)* 0.007
Female 9.52 (5.76, 15.74) < 0.001 8.68 (5.08, 14.83)* < 0.001
Overall obesity (BMI) 1.94 (1.10, 3.41) 0.021 -
Abdominal obesity 2.81 (1.80, 4.39) < 0.001 2.57 (1.51, 4.39)* 0.001
High systolic blood pressure 0.86 (1.56, 1.32) 0.494 -
High diastolic blood pressure 1.35 (0.86, 2.14) 0.195 1.53 (0.87, 2.69)* 0.137
Hyperglycaemia 1.05 (0.64, 1.71) 0.853 -
Hypertriglyceridemia 0.88 (0.57, 1.38) 0.588 -
Low HDL-cholesterol 1.97 (1.18, 3.31) 0.010 1.03 (0.58, 1.91)* 0.923
Metabolic syndrome 1.29 (0.82,2.02) 0.271 1.73 (1.02, 2.92)** 0.044
*Adjusted for age, sex, abdominal obesity, diastolic blood pressure, Low HDL-cholesterol
** Adjusted for age and sex
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was independently associated with an increased risk of
having metabolic syndrome. Our findings concur with
those in Western countries.
These findings have given rise to concerns about the
vitamin D status of the population in general and its
adverse effects on health. Urgent measures needed
should include the assessment of vitamin D status
among the population, more particularly in females.
Public health messages on the importance of vitamin D,
ways of achieving optimal vitamin D status and asso-
ciated cardio-metabolic risks should also be dissemi-
nated to the public.
However, these results may not be generalizable to the
entire Malaysian population as our participants were
urban Malays engaged in essentially indoor-based occu-
pations. We were also not able to measure the parathyr-
oid hormone (PTH) of these participants. PTH should
be included as a functional index of vitamin D status in
future studies. Other factors associated with low vitamin
D status such as dietary survey or physical activity pat-
tern should also be included in future studies. Compari-
son of vitamin D status between studies is difficult as
the definition of vitamin D insufficiency and deficiency,
as well as assay methodology of 25(OH)D vary between
studies. It is also noted that the sample size of this
study may have inadequate power to detect association
of vitamin D status with some metabolic risk factors.
On the other hand, this study remains as one of a few
studies on the vitamin D status and its association with
obesity and metabolic syndrome for both males and
females in Malaysia. This study is also timely as the
population has high prevalence of obesity [41]. Although
this study was confined to only Malay participants, this
could serve as a pilot study for future studies that
involve all races of the country.
Conclusions
This study highlights the high prevalence of vitamin D
insufficiency among Malay adults especially females in
Kuala Lumpur. Vitamin D insufficiency is associated
w i t hy o u n g e ra g e ,g e n d e r( f e m a l e )a n dg r e a t e ra b d o m -
inal obesity. Vitamin D insufficiency is also associated
with Metabolic Syndrome. Our findings concur with
those from the West.
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